Heska Corp (HSKA)
115.55
-0.14
(-0.12%)
USD |
NASDAQ |
May 26, 16:00
119.50
+3.95
(+3.42%)
Pre-Market: 20:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 1.261B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 20.38% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 4.702 |
| Price to Book Value | 3.019 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.2291 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 78.04% |
Profile
| Heska Corp is engaged in developing, manufacturing, marketing, selling, and supporting veterinary products. The company's products include Point of Care diagnostic laboratory instruments and consumables; Point of Care digital imaging diagnostic products; reference laboratory testing; digital cytology services; vaccines; local and cloud-based data services; allergy testing and immunotherapy; single-use offerings such as in-clinic diagnostic tests and heartworm preventive products; and practice information management software and related software. It operates through two segments North America and International. The Company's core strategic focus on Point of Care laboratory and imaging products is included in both segments. |
| URL | https://www.heska.com |
| Investor Relations URL | https://ir.heska.com/ |
| HQ State/Province | Colorado |
| Sector | Healthcare |
| Industry | Medical Devices |
| Equity Style | Small Cap/Growth |
| Next Earnings Release | Aug. 08, 2023 (est.) |
| Last Earnings Release | May. 05, 2023 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Sep. 26, 2012 |
Ratings
Profile
| Heska Corp is engaged in developing, manufacturing, marketing, selling, and supporting veterinary products. The company's products include Point of Care diagnostic laboratory instruments and consumables; Point of Care digital imaging diagnostic products; reference laboratory testing; digital cytology services; vaccines; local and cloud-based data services; allergy testing and immunotherapy; single-use offerings such as in-clinic diagnostic tests and heartworm preventive products; and practice information management software and related software. It operates through two segments North America and International. The Company's core strategic focus on Point of Care laboratory and imaging products is included in both segments. |
| URL | https://www.heska.com |
| Investor Relations URL | https://ir.heska.com/ |
| HQ State/Province | Colorado |
| Sector | Healthcare |
| Industry | Medical Devices |
| Equity Style | Small Cap/Growth |
| Next Earnings Release | Aug. 08, 2023 (est.) |
| Last Earnings Release | May. 05, 2023 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Sep. 26, 2012 |